Vamstar

Vamstar provides agentic AI solutions for commercial operations in the life sciences industry, equipping MedTech, Pharma, and Biotech teams with purpose-built AI for tendering, pricing, market access, and contract management. The company's Polaris platform delivers advanced data science and AI solutions including tender and RFx matching, price optimization, value analysis, and value-based pricing and ESG tracking. Vamstar's product suite includes Contracts AI for automating RFP, RFQ, and tender analysis with CRM integration; Pricing AI for real-time pricing insights using award data and market trends with active learning; and Value AI for evidence mapping, policy intelligence, and market surveillance. The platform leverages natural language processing and machine learning to analyze tender documents at scale, demonstrated by processing over 15,000 tender documents for MedTech Europe's ESG criteria study. Vamstar reports 92% of organizations improved data intelligence coverage, 20x improvement in operating environment efficiency, and 7.5% margin profile improvements. Founded in 2019 and headquartered in London, United Kingdom, the company has raised approximately $11.2M in Series A funding from investors including Antler, Begin Capital, b2venture, AIC, Dutch Founders Fund, Celltrion, Mirae Asset Global Investments, Mainspring Fund Services, and BtoV. Vamstar differentiates itself through its agentic AI platform purpose-built for life sciences commercial operations, trained on real-world tender and pricing data to deliver measurable margin impact across pharmaceutical, biotech, and medical device organizations.